Animace načítání

Stránka se připravuje...


Na co čekáte? Nečekejte už ani minutu.
Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.

XXŘ&Xxxxxx;XXX&Xxxxxx; XXXXXX (XX) č. 944/2013

ze dne 2. října 2013,

xxxx&xxxxxx;x xx xxx &xxxxxx;čxxx xřxxxůxxxxx&xxxxxx; xěxxxxxxxxxxxxx&xxxxxx;xx xxxxxxx xěx&xxxxxx; xxř&xxxxxx;xxx&xxxxxx; Evropského xxxxxxxxxx a Rady (ES) č.&xxxx;1272/2008 x&xxxx;xxxxxxxxxxx, xxxxčxx&xxxxxx;x&xxxxxx; x&xxxx;xxxxx&xxxxxx; x&xxxxxx;xxx x&xxxx;xxěx&xxxxxx;

(Xxxx x x&xxxxxx;xxxxxx xxx XXX)

XXXXXXX&Xxxxxx; XXXXXX,

x xxxxxxx xx Smlouvu o xxxxxx&xxxxxx;x&xxxxxx; Evropské xxxx,

x xxxxxxx xx xxř&xxxxxx;xxx&xxxxxx; Xxxxxxx&xxxxxx;xx xxxxxxxxxx a Xxxx (ES) č. 1272/2008 ze xxx 16. xxxxxxxx 2008 x xxxxxxxxxxx, označování x xxxxx&xxxxxx; x&xxxxxx;xxx x směsí, x xxěxě x xxx&xxxxxx;xx&xxxxxx; xxěxxxx 67/548/XXX x 1999/45/XX x x xxěxě xxř&xxxxxx;xxx&xxxxxx; (ES) č. 1907/2006 (1), a xxxx&xxxxxx;xx xx čl. 37 odst. 5 x čx&xxxxxx;xxx 53 xxxxxx&xxxxxx;xx xxř&xxxxxx;xxx&xxxxxx;,

xxxxxxxx x xěxxx xůxxxůx:

(1)

Xxxxx xxx x xxxxxx pro xxxxxčx&xxxxxx; xxxx&xxxxxx;xxx&xxxxxx; X210 xxxxxxxx&xxxxxx; x xxxxxxx 6.2 části 1 xř&xxxxxx;xxxx XX xxř&xxxxxx;xxx&xxxxxx; (XX) č. 1272/2008, xx&xxxxxx;xx x x&xxxxxx;xxx x&xxxxxx;x&xxxxxx; xxxxxx Globálně xxxxxxxxxxxx&xxxxxx;xx xxxx&xxxxxx;xx xxxxxxxxxxx x xxxxčxx&xxxxxx;x&xxxxxx; xxxxxxx&xxxxxx;xx x&xxxxxx;xxx XXX (dále xxx „GHS“) xx xxěx&xxxxxx;x, xxž nebyly x xxř&xxxxxx;xxx&xxxxxx; Komise (XX) č. 487/2013 (2) x xxx&xxxxxx; míře xxxxxxxěxx. X x&xxxxxx;xxx xxxxxžxxxxx je xxxxxxx&xxxxxx; xxxxxxxx mezi XXX x xxř&xxxxxx;xxx&xxxxxx;x (XX) č. 1272/2008 plný xxxxxx.

(2)

Č&xxxxxx;xx 3 přílohy XX xxř&xxxxxx;xxx&xxxxxx; (ES) č. 1272/2008 obsahuje xxx seznamy xxxxxxxxxxxx&xxxxxx;xx xxxxxxxxxx&xxxxxx; x označení xxxxxxxčx&xxxxxx;xx x&xxxxxx;xxx. X xxxxxxx 3.1 xx xxxxxx seznam xxxxxxxxxxxx&xxxxxx;xx xxxxxxxxxx&xxxxxx; a xxxxčxx&xxxxxx; xxxxxxxčx&xxxxxx;xx látek na x&xxxxxx;xxxxě xxxx&xxxxxx;xx&xxxxxx; stanovených x č&xxxxxx;xxxxx 2 xž 5 přílohy X xxř&xxxxxx;xxx&xxxxxx; (ES) č. 1272/2008. V xxxxxxx 3.2 xx xxxxxx xxxxxx harmonizovaných xxxxxxxxxx&xxxxxx; a xxxxčxx&xxxxxx; xxxxxxxčx&xxxxxx;xx x&xxxxxx;xxx xx x&xxxxxx;xxxxě xxxx&xxxxxx;xx&xxxxxx; xxxxxxxx&xxxxxx;xx x xř&xxxxxx;xxxx XX xxěxxxxx Xxxx 67/548/XXX xx xxx 27. čxxxxx 1967 x xxxxžxx&xxxxxx;x&xxxxxx; právních x xxx&xxxxxx;xx&xxxxxx;xx předpisů x&xxxxxx;xxx&xxxxxx;x&xxxxxx;xx xx xxxxxxxxxxx, balení x označování nebezpečných x&xxxxxx;xxx (3). Xxxx dva xxxxxxx je xxxx&xxxxxx; xxěxxx, aby do xxxx xxxx zahrnuty xxxxxxxxxxxx&xxxxxx; xxxxxxxxxxx x&xxxxxx;xxx, xx které xx xxž xxxxxxxx xxxxxxxxxxxx&xxxxxx; xxxxxxxxxxx, x xxx xxxxxxxxxx x xxx&xxxxxx; xxxxxxxxxxxx&xxxxxx; xxxxxxxxxxx.

(3)

X&xxxxxx;xxx xxx xxxxxxx&xxxxxx;x&xxxxxx; rizik (XXX) Xxxxxxx&xxxxxx; xxxxxxxx pro xxxxxxx&xxxxxx; x&xxxxxx;xxx (XXXX) xxxxx stanoviska k x&xxxxxx;xxxůx xxxxxxxxxxxx&xxxxxx; xxxxxxxxxxx x označování látek, xxxx&xxxxxx; byly předloženy xxxxxxřx x souladu x čx&xxxxxx;xxxx 37 xxř&xxxxxx;xxx&xxxxxx; (XX) č. 1272/2008. Xx x&xxxxxx;xxxxě xěxxxx xxxxxxxxxx x xx x&xxxxxx;xxxxě xřxxxx&xxxxxx;xxx xxxxžxx&xxxxxx;xx xx xxxčxx&xxxxxx;xx xxxxx xx třeba xxěxxx xř&xxxxxx;xxxx VI xxř&xxxxxx;xxx&xxxxxx; (XX) č. 1272/2008, xxx xxxx xxxxžxxx xxxxxxxxxxx xxxxxxxxxxx x xxxxčxx&xxxxxx;x&xxxxxx; xěxxxx&xxxxxx;xx x&xxxxxx;xxx.

(4)

Xxxxxxxxxxxx&xxxxxx; xxxxxxxxxxx stanovené x části 3 xř&xxxxxx;xxxx VI nařízení (XX) č. 1272/2008, xx xxěx&xxxxxx; xxxxxx xxř&xxxxxx;xxx&xxxxxx;, by xx xxxěxx použít xxxxxxxxřxxxě, xxxxť xxxxxx&xxxxxx;řxx&xxxxxx; subjekty xxxxx xxxřxxxxxx určité xxxxx&xxxxxx; xx to, xxx xxxxx xxx&xxxxxx;x xxxxxxxxxx&xxxxxx;x xřxxxůxxxxx označování x xxxxx&xxxxxx; x&xxxxxx;xxx x xxěx&xxxxxx; x xxxxxx existující zásoby. Xxxxxx&xxxxxx;řxx&xxxxxx; subjekty xxxxx xxxxě toho xxxřxxxxxx xxčxx&xxxxxx; časové xxxxx&xxxxxx; xx to, aby xxxxx xxxxxx xxxxxxxxxx xxx xxxxxxxxxx, které xxxx&xxxxxx;xxx&xxxxxx; x xxx&xxxxxx;xx xxxxxxxxxxxx&xxxxxx;xx xxxxxxxxxx&xxxxxx; x&xxxxxx;xxx xxxxxxxxxxxx&xxxxxx;xx xxxx xxxxxxxxxxx&xxxxxx;, xxxxxxxx&xxxxxx; xxxx xxxxxx&xxxxxx; xxx reprodukci, xxxxxxxx&xxxxxx; 1X x 1B (xxxxxxx 3.1) a xxxxxxxx&xxxxxx; 1 x 2 (xxxxxxx 3.2) xxxx xxxx vysoce xxxxxx&xxxxxx; pro xxxx&xxxxxx; xxxxxxxxx x možností xxxxxxx dlouhodobé xxxř&xxxxxx;xxxx&xxxxxx; &xxxxxx;čxxxx xx xxxx&xxxxxx;x xxxxxřxx&xxxxxx;, zejména xxx xxxxxxxxxx stanovené x čx&xxxxxx;xxx 23 xxř&xxxxxx;xxx&xxxxxx; Xxxxxxx&xxxxxx;xx parlamentu x Xxxx (ES) č. 1907/2006 ze xxx 18. prosince 2006 x xxxxxxxxxx, hodnocení, xxxxxxx&xxxxxx;x&xxxxxx; a omezování xxxxxxx&xxxxxx;xx x&xxxxxx;xxx, x xř&xxxxxx;xxx&xxxxxx; Evropské xxxxxxxx xxx chemické látky, x změně xxěxxxxx 1999/45/XX x x xxx&xxxxxx;xx&xxxxxx; nařízení Rady (XXX) č. 793/93, xxř&xxxxxx;xxx&xxxxxx; Xxxxxx (XX) č. 1488/94, xxěxxxxx Xxxx 76/769/EHS x xxěxxxx Komise 91/155/EHS, 93/67/XXX, 93/105/XX x 2000/21/XX (4).

(5)

Xxxxx jde x x&xxxxxx;xxx &xxxxx;xxxxx, coal xxx, high-temp.“ (smola, čxxxxxxxxx&xxxxxx; dehet, vysokoteplotní, č. XX: 266-028-2), xxxxxx&xxxxxx;řxx&xxxxxx; subjekty budou xxxřxxxxxx delší čxxxx&xxxxxx; xxxxx&xxxxxx; na xx, xxx mohly xxxxxx xxxxxxxxxx, které xxxx&xxxxxx;xxx&xxxxxx; x xxx&xxxxxx;xx xxxxxxxxxxxx&xxxxxx;xx xxxxxxxxxx&xxxxxx; látek xxxxxxxxxxxx&xxxxxx;xx xxxx vysoce xxxxxx&xxxxxx; xxx xxxx&xxxxxx; xxxxxxxxx x xxžxxxx&xxxxxx; xxxxxxx xxxxxxxxx&xxxxxx; xxxř&xxxxxx;xxxx&xxxxxx; účinky xx xxxx&xxxxxx;x prostředí, x to zejména xxxxxxxxxx xxxxxxxx&xxxxxx; x čx&xxxxxx;xxx 3 x x xř&xxxxxx;xxxx XXX xxěxxxxx Xxxxxxx&xxxxxx;xx xxxxxxxxxx x Rady 2008/68/ES xx xxx 24. x&xxxxxx;ř&xxxxxx; 2008 x xxxxxx&xxxxxx; xřxxxxxě nebezpečných xěx&xxxxxx; (5). Xěxx by xxxxx být stanoveno xxx&xxxxxx;&xxxxxx; xřxxxxxx&xxxxxx; období, xxž xx začne xxxxxňxxxx harmonizovaná xxxxxxxxxxx.

(6)

Pokud xxx x x&xxxxxx;xxx &xxxxx;xxxxxxx arsenide“ (xxxxxxx xxxxxx&xxxxxx;, č. ES: 215-114-8), x&xxxxxx;xxx XXX xxxxxxxx&xxxxxx;x&xxxxxx; nové stanovisko xxxxxxě třídy xxxxxxxčxxxxx &xxxxx;xxxxxxxx pro reprodukci“. Xxxx xř&xxxxxx;xx xxxxxxxčxxxxx xx xx xxxxx xxxěxx xxřxxxxxx do xř&xxxxxx;xxxx VI xxř&xxxxxx;xxx&xxxxxx; (XX) č. 1272/2008, xxxxx toto xxxxxxxxxx xxxxxx xxxxxčxxx.

(7)

Pokud xxx x x&xxxxxx;xxx „polyhexamethylene xxxxxxxxx xxxxxxxxxxxxx&xxxxx; (xxxxxxxxxxxxxxxx-xxxxxxxx xxxxxxxxxxxx, č. CAS: 27083-27-8 nebo 32289-58-0), xxxx xxx&xxxxxx; x xxxxxxxxx xxx&xxxxxx; xěxxxx&xxxxxx; &xxxxxx;xxxx pro xř&xxxxxx;xx xxxxxxxčxxxxx „akutní xxxxxxxx (xxxxxxčx&xxxxxx;)&xxxxx;, xxž naznačuje, žx xxxxxxxxxxx pro xxxx xř&xxxxxx;xx xxxxxxxčxxxxx xxxxxxčxxxx&xxxxxx; ve xxxxxxxxxx x&xxxxxx;xxxx XXX, xxž xx zakládá xx xxxx&xxxxxx;&xxxxxx;xx &xxxxxx;xxx&xxxxxx;xx, by xxxxxxxx být xřxxěřxx&xxxxxx;. Xxxx xř&xxxxxx;xx nebezpečnosti xx xx xxxxx xxxěxx zařazovat xx xř&xxxxxx;xxxx XX xxř&xxxxxx;xxx&xxxxxx; (XX) č. 1272/2008, xxxxx x&xxxxxx;xxx XXX xxxěx příležitost xxxxx xxxxxxxxxx x novým xxxxxxxx&xxxxxx;x, xxx&xxxxxx;xxx x&xxxxxx;xxxxx xxxxxx&xxxxxx; xř&xxxxxx;xx xxxxxxxčxxxxx xxxxžxx&xxxxxx; ve stanovisku x&xxxxxx;xxxx RAC xx xxřxxxxx x&xxxxxx;x xěxx.

(8)

V xxxxxxx x přechodnými xxxxxxxxx&xxxxxx;xx xxř&xxxxxx;xxx&xxxxxx; (XX) č. 1272/2008, xxž xxxžňxx&xxxxxx; xxxžxx&xxxxxx; nových xxxxxxxxx&xxxxxx; x předstihem xx x&xxxxxx;xx dobrovolnosti, xx měli mít xxxxxxxxx&xxxxxx; xxžxxxx xxxž&xxxxxx;xxx xxxxxxxxxxxxxx xxxxxxxxxxx stanovenou x č&xxxxxx;xxx 3 xř&xxxxxx;xxxx XX xxř&xxxxxx;xxx&xxxxxx; (XX) č. 1272/2008, xx xxěx&xxxxxx; tohoto xxř&xxxxxx;xxx&xxxxxx;, a xřxxxůxxxxx xxxxčxx&xxxxxx;x&xxxxxx; a xxxxx&xxxxxx; xxxxx&xxxxxx;xxx&xxxxxx;x&xxxxxx;x způsobem xx xxxxxxxxx&xxxxxx; x&xxxxxx;xx xřxx xxxx, x xxxž xx harmonizované xxxxxxxxxxx xxxxxx xxxxxx&xxxxxx;xx.

(9)

Xxxxřxx&xxxxxx; xxxxxxxx&xxxxxx; x&xxxxxx;xxx xxř&xxxxxx;xxx&xxxxxx;x jsou x xxxxxxx se xxxxxxxxxxx výboru xř&xxxxxx;xxx&xxxxxx;xx xxxxx čx&xxxxxx;xxx 133 xxř&xxxxxx;xxx&xxxxxx; (ES) č. 1907/2006,

XŘXXXXX TOTO XXŘ&Xxxxxx;XXX&Xxxxxx;:

Čx&xxxxxx;xxx 1

Xxř&xxxxxx;xxx&xxxxxx; (ES) č. 1272/2008 se xěx&xxxxxx; xxxxx:

1)

Příloha XX xx xěx&xxxxxx; v xxxxxxx s přílohou X xxxxxx xxř&xxxxxx;xxx&xxxxxx;.

2)

Č&xxxxxx;xx 3 přílohy XX xx xěx&xxxxxx; xxxxx:

x)

xxxxxxx 3.1 se mění xxxxx:

x)

x&xxxxxx;xxxxx xxxxxx&xxxxxx; x xř&xxxxxx;xxxx XX xxř&xxxxxx;xxx&xxxxxx; (XX) č. 1272/2008, xxxx&xxxxxx; xxxxx&xxxxxx;xxx&xxxxxx; x&xxxxxx;xxxxůx xxxxxx&xxxxxx;x x xř&xxxxxx;xxxx XX tohoto nařízení, xx nahrazují záznamy xxxxxx&xxxxxx;xx x příloze XX xxxxxx nařízení,

xx)

záznamy xxxxxx&xxxxxx; x xř&xxxxxx;xxxx XXX tohoto nařízení xx xxx&xxxxxx;xxx&xxxxxx; x xxxxxxx x xxxxxxxxxxx&xxxxxx; x&xxxxxx;xxxxů uvedených x xxxxxxx 3.1;

x)

tabulka 3.2 xx xěx&xxxxxx; xxxxx:

x)

x&xxxxxx;xxxxx xxxxxx&xxxxxx; x xř&xxxxxx;xxxx XX xxř&xxxxxx;xxx&xxxxxx; (ES) č. 1272/2008, které xxxxx&xxxxxx;xxx&xxxxxx; x&xxxxxx;xxxxůx uvedeným x xř&xxxxxx;xxxx XX xxxxxx xxř&xxxxxx;xxx&xxxxxx;, xx xxxxxxxx&xxxxxx; záznamy uvedenými x xř&xxxxxx;xxxx IV xxxxxx xxř&xxxxxx;xxx&xxxxxx;,

xx)

x&xxxxxx;xxxxx xxxxxx&xxxxxx; x xř&xxxxxx;xxxx X xxxxxx xxř&xxxxxx;xxx&xxxxxx; xx xxx&xxxxxx;xxx&xxxxxx; x souladu x posloupností x&xxxxxx;xxxxů xxxxxx&xxxxxx;xx x xxxxxxx 3.2.

Čx&xxxxxx;xxx 2

1.   Odchylně xx čx. 3 xxxx. 2 xxxxx být x&xxxxxx;xxx x xxěxx xxxxxxxxxx&xxxxxx;xx, xxxxčxx&xxxxxx;xx x xxxxxx x souladu x xxř&xxxxxx;xxx&xxxxxx;x (XX) č. 1272/2008 xx xxěx&xxxxxx; tohoto xxř&xxxxxx;xxx&xxxxxx; xřxx 1. prosincem 2014, resp. 1. čxxxxxx 2015.

2.&xxxx;&xxxx;&xxxx;Xxxxxxxě od čx. 3 xxxx. 2 nemusí x&xxxxxx;x x&xxxxxx;xxx xxxxxxxxxxxx&xxxxxx;, xxxxčxxxx&xxxxxx; x xxxxx&xxxxxx; x xxxxxxx x nařízením (XX) č. 1272/2008 x uváděné na xxx xřxx 1. xxxxxxxxx 2014 znovu xxxxčxxx a xxxxxxxx x souladu s xxř&xxxxxx;xxx&xxxxxx;x (XX) č. 1272/2008 xx xxěx&xxxxxx; xxxxxx xxř&xxxxxx;xxx&xxxxxx;, x xx xž xx 1. xxxxxxxx 2016.

3.&xxxx;&xxxx;&xxxx;Xxxxxxxě xx čl. 3 xxxx. 2 xxxxx&xxxxxx; x&xxxxxx;x xxěxx klasifikované, xxxxčxxxx&xxxxxx; x balené x xxxxxxx xx xxěxxxx&xxxxxx; Xxxxxxx&xxxxxx;xx xxxxxxxxxx x Xxxx 1999/45/ES (6) xxxx nařízením (XX) č. 1272/2008 x xxxxxx&xxxxxx; na xxx xřxx 1. čxxxxxx 2015 znovu xxxxčxxx x zabaleny v xxxxxxx x nařízením (XX) č. 1272/2008 xx xxěx&xxxxxx; xxxxxx xxř&xxxxxx;xxx&xxxxxx;, x xx xž do 1. čxxxxx 2017.

4.   Odchylně xx čx. 3 xxxx. 3 lze xxxxxxxxxxxx&xxxxxx; xxxxxxxxxxx xxxxxxxx&xxxxxx; x č&xxxxxx;xxx 3 xř&xxxxxx;xxxx XX xxř&xxxxxx;xxx&xxxxxx; (XX) č. 1272/2008, ve xxěx&xxxxxx; tohoto nařízení, xxxž&xxxxxx;x xřxx daty xxxxxx&xxxxxx;xx v čx. 3 xxxx. 3.

Čx&xxxxxx;xxx 3

1.&xxxx;&xxxx;&xxxx;Xxxx xxř&xxxxxx;xxx&xxxxxx; xxxxxxxx x xxxxxxxx xxxx&xxxxxx;x&xxxxxx;x dnem xx xxxx&xxxxxx;&xxxxxx;xx&xxxxxx; x Úředním xěxxx&xxxxxx;xx Evropské xxxx.

2.&xxxx;&xxxx;&xxxx;Xxxxxxxxx&xxxxxx; čx. 1 odst. 1 xx xxx x&xxxxxx;xxx xxxžxxx xx 1. xxxxxxxx 2014 x xxx směsi xx 1. čxxxxx 2015.

3.&xxxx;&xxxx;&xxxx;Xxxxxxxxx&xxxxxx; čx. 1 xxxx. 2 xx xxxžxx&xxxxxx; xxx xxx 1. xxxxx 2015 xxx všechny xxxxžxx xxxxx xxxxžxx „pitch, xxxx xxx, xxxx-xxxx.&xxxxx; (xxxxx, čxxxxxxxxx&xxxxxx; xxxxx, xxxxxxxxxxxxx&xxxxxx;, č. XX: 266-028-2), xxx kterou xx čx&xxxxxx;xxx 1 xxxžxxx xxx xxx 1. xxxxx 2016.

Xxxx nařízení xx x&xxxxxx;xxxx&xxxxxx; x celém xxxxxxx x xř&xxxxxx;xx xxxžxxxxx&xxxxxx; ve všech čxxxxx&xxxxxx;xx xx&xxxxxx;xxxx.

X Bruselu xxx 2. ř&xxxxxx;xxx 2013.

Xx Komisi

Xxx&xxxxxx; Manuel XXXXXXX

xřxxxxxx

(1)&xxxx;&xxxx;&Xxxxxx;ř. xěxx. X 353, 31.12.2008, x. 1.

(2)&xxxx;&xxxx;&Xxxxxx;ř. xěxx. X 149, 1.6.2013, x. 1.

(3)&xxxx;&xxxx;&Xxxxxx;ř. věst. 196, 16.8.1967, x. 1.

(4)&xxxx;&xxxx;&Xxxxxx;ř. xěxx. X 396, 30.12.2006, x. 1.

(5)&xxxx;&xxxx;&Xxxxxx;ř. věst. X 260, 30.9.2008, x. 13.

(6)&xxxx;&xxxx;&Xxxxxx;ř. xěxx. L 200, 30.7.1999, x. 1.

XŘ&Xxxxxx;XXXX X

X části 1 xxxxxxx 6.2 xř&xxxxxx;xxxx XX xxř&xxxxxx;xxx&xxxxxx; (XX) č. 1272/2008 xx x&xxxxxx;x X210 xxxxxxxxx tímto:

&xxxxx;X210

Xxxxňxx xřxx xxxxxx, xxxx&xxxxxx;xx xxxxxxx, xxxxxxxx, xxxxřxx&xxxxxx;x plamenem x jinými zdroji xxx&xxxxxx;xxx&xxxxxx;. X&xxxxxx;xxx xxxřxx&xxxxxx;.

Výbušniny (xxx&xxxxxx;x 2.1)

Xxxxř&xxxxxx;xx 1.1, 1.2, 1.3, 1.4, 1.5

&xxxx;

Xxřxxx&xxxxxx; plyny (xxx&xxxxxx;x 2.2)

1, 2

Xxxxxxxx (xxx&xxxxxx;x 2.3)

1, 2, 3

Hořlavé xxxxxxxx (xxx&xxxxxx;x 2.6)

1, 2, 3

Hořlavé tuhé x&xxxxxx;xxx (xxx&xxxxxx;x 2.7)

1, 2

Xxxxxxxxě xxxxxx&xxxxxx;x&xxxxxx; x&xxxxxx;xxx x směsi (xxx&xxxxxx;x 2.8)

Xxxx X, X, X, X, X, X

Xxxxx&xxxxxx;xxxx&xxxxxx; kapaliny (oddíl 2.9)

1

Xxxxx&xxxxxx;xxxx&xxxxxx; xxx&xxxxxx; x&xxxxxx;xxx (xxx&xxxxxx;x 2.10)

1

Xxxxxx&xxxxxx;x&xxxxxx; xxxxxxxx (xxx&xxxxxx;x 2.13)

1, 2, 3

Xxxxxx&xxxxxx;x&xxxxxx; xxx&xxxxxx; látky (xxx&xxxxxx;x 2.14)

1, 2, 3

Xxxxxxxx&xxxxxx; xxxxxxxx (oddíl 2.15)

Xxxx A, B, X, X, X, X&xxxxx;

XŘ&Xxxxxx;XXXX II

Xxxxxxx&xxxxxx; č&xxxxxx;xxx

Xxxxx&xxxxxx;xxxx&xxxxxx; xxxxxxxxxxxx xxxxxxx&xxxxxx;xx x&xxxxxx;xxx

Číslo XX

Č&xxxxxx;xxx CAS

Xxxxxxxxxxx

Označení

Xxxxxxxxx&xxxxxx; xxxxxxx. xxxxxx,

xxxxxxxxxxčx&xxxxxx; xxxxxxx

Xxxx.

Kódy tříd x xxxxxxxx&xxxxxx; xxxxxxxčxxxxx

X&xxxxxx;xx xxxxxxxxx&xxxxxx;xx xěx x xxxxxxxčxxxxx

X&xxxxxx;xx x&xxxxxx;xxxxžx&xxxxxx;xx symbolů x xxxx&xxxxxx;xx&xxxxxx;xx slov

X&xxxxxx;xx xxxxxxxxx&xxxxxx;xx xěx x xxxxxxxčxxxxx

X&xxxxxx;xx doplň. standardních xěx x xxxxxxxčxxxxx

015-004-00-8

xxxxxxxxx xxxxxxxxx

244-088-0

20859-73-8

Xxxxx-xxxxx. 1

X260

XXX02

H260

EUH029

X = 100

&xxxx;

Xxxxx Xxx. 2

X300

GHS06

X300

XXX032

&xxxx;

Xxxxx Xxx. 3

X311

GHS09

H311

&xxxx;

Acute Xxx. 1

X330

Xxx

X330

&xxxx;

Xxxxxxx Xxxxx 1

X400

&xxxx;

X400

&xxxx;

015-005-00-3

magnesium xxxxxxxxx;

xxxxxxxxxxxx xxxxxxxxxxx

235-023-7

12057-74-8

Water-react. 1

H260

GHS02

X260

EUH029

X = 100

&xxxx;

Xxxxx Xxx. 2

X300

XXX06

X300

XXX032

&xxxx;

Xxxxx Xxx. 3

H311

XXX09

X311

 

Acute Xxx. 1

H330

Xxx

H330

 

Xxxxxxx Acute 1

X400

&xxxx;

X400

&xxxx;

015-123-00-5

xxxxxxxxxx (XXX);

xxxxx-4-xxxxxxxxxx-x-xxxxx isopropyl xxxxxxxxxxxxxxx

244-848-1

22224-92-6

Xxxxx Xxx. 2

X300

GHS06

H300

&xxxx;

X = 100

M = 100

&xxxx;

Xxxxx Xxx. 2

X310

GHS09

H310

Acute Xxx. 2

H330

Xxx

X330

Xxx Xxxxx. 2

X319

&xxxx;

X319

Xxxxxxx Xxxxx 1

H400

 

&xxxx;

Xxxxxxx Xxxxxxx 1

X410

&xxxx;

X410

030-012-00-1

xxxxxxxxx-xxxxxxxxx-xxxx-xxxxxxxxx-xxxxxxxxx

423-570-6

169314-88-9

Xxxxxxx Xxxxxxx 4

X413

&xxxx;

X413

&xxxx;

&xxxx;

&xxxx;

602-006-00-4

xxxxxxxxxx;

xxxxxxxxxxxxxxxx

200-663-8

67-66-3

Xxxx. 2

X351

XXX06

X351

 

 

&xxxx;

Repr. 2

X361x

GHS08

X361x

Acute Xxx. 3

X331

Xxx

X331

Xxxxx Tox. 4

X302

&xxxx;

X302

XXXX RE 1

X372

 

H372

Eye Xxxxx. 2

X319

&xxxx;

X319

Skin Xxxxx. 2

X315

&xxxx;

X315

603-097-00-3

1,1&xxxxx;,1&xxxxx;-xxxxxxxxxxxxxxxx-2-xx;

xxxxxxxxxxxxxxxxxxx

204-528-4

122-20-3

Xxx Irrit. 2

X319

XXX07

Xxx

X319

&xxxx;

&xxxx;

&xxxx;

605-008-00-3

xxxxxxxx;

xxxx-2-xxxx;

xxxxxxxxxxxxx

203-453-4

107-02-8

Xxxx. Xxx. 2

X225

XXX02

H225

EUH071

Xxxx Xxxx. 1; X314: X &xx; 0,1 %

X

Xxxxx Xxx. 1

X330

XXX06

X330

&xxxx;

Xxxxx Xxx. 2

X300

XXX05

X300

&xxxx;

Xxxxx Xxx. 3

X311

XXX09

X311

 

Xxxx Xxxx. 1

X314

Xxx

X314

&xxxx;

Xxxxxxx Xxxxx 1

H400

&xxxx;

 

 

M = 100

Aquatic Chronic 1

X410

&xxxx;

X410

&xxxx;

X = 1

607-023-00-0

xxxxx xxxxxxx

203-545-4

108-05-4

Xxxx. Xxx. 2

X225

XXX02

H225

&xxxx;

 

X

Xxxx. 2

X351

XXX08

X351

&xxxx;

&xxxx;

Xxxxx Xxx. 4

H332

GHS07

X332

&xxxx;

&xxxx;

STOT XX 3

H335

Dgr

X335

&xxxx;

&xxxx;

607-613-00-8

xxxxxxxx xxxx xx:

&xxxx;

xxxxxxxx acid

&xxxx;

xxxxxxxxxxxxxxx acid

&xxxx;

xxxxxxxxxxxxx xxxx

&xxxx;

xxxxxxxxxx xxxxx xx xxxxxxxx xxxx

&xxxx;

xxxxxxxxxx xxxxx xx xxxxxxxxxxx xxxx

&xxxx;

dimethyl xxxxxxxxx xxxxxxxx acid

 

monoperglutaric xxxx

&xxxx;

xxxxxxxxxxxxx acid

&xxxx;

xxxxxxxxxx xxxxx xx xxxxxxxx xxxx

&xxxx;

xxxxxxxxxx xxxxx xx xxxxxxxxxxx xxxx

&xxxx;

xxxxxxxx glutarate adipic xxxx

&xxxx;

xxxxxxxxxxxxx xxxx

&xxxx;

xxxxxxxxxxx xxxx

 

monomethyl xxxxx xx xxxxxx xxxx

&xxxx;

xxxxxxxxxx xxxxx xx xxxxxxxxx acid

 

xxxxxxxx xxxxxxx

&xxxx;

xxxxxxxx xxxxxxxx

&xxxx;

xxxxxxxx

&xxxx;

xxxxx

432-790-1

&xxxx;

Xxxxx Tox. 4*

X332

XXX07

X332

&xxxx;

 

&xxxx;

Xxxxx Xxx. 4*

X312

XXX05

X312

Xxxxx Tox. 4*

X302

XXX08

X302

Xxxx Corr. 1X

H314

Xxx

X314

STOT XX 2

H371 (xxxx)

&xxxx;

H371 (xxxx)

609-003-00-7

xxxxxxxxxxxx

202-716-0

98-95-3

Xxxx. 2.

X351

XXX06

X351

 

&xxxx;

 

Repr. 1B

X360X

XXX08

H360F

Xxxxx Xxx. 3

H301

Xxx

X301

Xxxxx Xxx. 3

X331

&xxxx;

X331

Xxxxx Tox. 3

X311

&xxxx;

H311

XXXX XX 1

X372 (blood)

 

H372 (xxxxx)

Xxxxxxx Xxxxxxx 3

X412

 

H412

612-120-00-6

xxxxxxxxx (XXX);

2-xxxxxx-6-xxxxx-3-xxxxxxxxxxxxxx

277-704-1

74070-46-5

Xxxx. 2

X351

GHS08

H351

&xxxx;

M = 100

X = 10

&xxxx;

Xxxx Xxxx. 1 X

X317

XXX07

X317

&xxxx;

Xxxxxxx Xxxxx 1

X400

XXX09

 

&xxxx;

Xxxxxxx Xxxxxxx 1

X410

Xxx

X410

&xxxx;

613-175-00-9

xxxxxxxxxxxxx (XXX);

(2XX,3XX)-3-(2-xxxxxxxxxxxx)-2-(4-xxxxxxxxxxxx)-[( 1X-1,2,4-xxxxxxx-1-xx)xxxxxx]xxxxxxx

406-850-2

133855-98-8

Carc. 2

X351

XXX08

X351

&xxxx;

&xxxx;

&xxxx;

Xxxx. 1X

X360Xx

XXX09

X360Xx

Aquatic Xxxxxxx 2

X411

Xxx

X411

616-200-00-1

xxxxxxxx mass xx X,X&xxxxx;-xxxxxx-1,2-xxxxxxx(xxxxxxxxxx) xxx 12-xxxxxxx-X-[2-[(1-xxxxxxxx)xxxxx]xxxxx]xxxxxxxxxxxxxx xxx X,X&xxxxx;-xxxxxx-1,2-xxxxxxx(12-xxxxxxxxxxxxxxxx xxxxx)

432-430-3

&xxxx;

Xxxxxxx Xxxxxxx 4

X413

&xxxx;

X413

 

 

 

648-055-00-5

xxxxx, xxxx xxx, xxxx-xxxx.;

[The residue xxxx xxx distillation xx xxxx temperature xxxx tar. A xxxxx xxxxx xxxx xx xxxxxxxxxxx xxxxxxxxx xxxxx from 30 °C xx 180&xxxx;&xxx;X (86 °F xx 356&xxxx;&xxx;X). Xxxxxxxx xxxxxxxxx xx a xxxxxxx xxxxxxx of xxxxx xx xxxx xxxxxxxx xxxxxxxxx xxxx xxxxxxxx xxxxxxxxxxxx.]

266-028-2

65996-93-2

Xxxx. 1 X

X350

XXX08

X350

&xxxx;

X = 1000

X = 1000

 

Xxxx. 1X

H340

XXX09

X340

&xxxx;

Xxxx. 1X

X360XX

Xxx

X360XX

&xxxx;

Xxxxxxx Acute 1

X400

&xxxx;

&xxxx;

 

Aquatic Xxxxxxx 1

H410

&xxxx;

H410

&xxxx;

649-330-00-2

naphtha (xxxxxxxxx), xxxxxxxxxxxxxxxxxx xxxxx;

Xxx xxxxxxx xxxxx hydrogen xxxxxxx xxxxxxx;

[X xxxxxxx combination xx xxxxxxxxxxxx obtained xxxx x xxxxxxxxx xxxxxxxxxxxxxxxxxxxx xxxxxxx. It xxxxxxxx of hydrocarbons xxxxxx carbon xxxxxxx xxxxxxxxxxxxx xx xxx xxxxx xx C7 xxxxxxx C12 xxx xxxxxxx xx xxx xxxxx of xxxxxxxxxxxxx 90&xxxx;&xxx;X to 230 °C (194&xxxx;&xxx;X xx 446&xxxx;&xxx;X).]

265-185-4

64742-82-1

Xxxx. 1X

X350

XXX08

X350

&xxxx;

&xxxx;

X

Xxxx. 1X

H340

Xxx

X340

STOT RE 1

X372 (xxxxxxx nervous xxxxxx)

&xxxx;

X372 (xxxxxxx nervous xxxxxx)

Xxx. Xxx. 1

H304

&xxxx;

X304

649-345-00-4

xxxxxxxx xxxxxxx;

Xxx xxxxxxx xxxxx xxxxxxx &xxxxx; xxxxxxxxxxx;

[A xxxxxxxxxx, xxxxxxx petroleum xxxxxxxxxx that xx xxxx xxxx rancid xx objectionable odours xxx xxxx xxxxx xx x xxxxx xx xxxxxxxxxxxxx 148,8 °C xx 204,4&xxxx;&xxx;X (300 °F xx 400&xxxx;&xxx;X).]

232-489-3

8052-41-3

Xxxx. 1X

X350

XXX08

H350

&xxxx;

&xxxx;

X

Xxxx. 1X

X340

Xxx

X340

XXXX XX 1

H372 (xxxxxxx xxxxxxx xxxxxx)

&xxxx;

H372 (xxxxxxx xxxxxxx xxxxxx)

Xxx. Xxx. 1

H304

&xxxx;

X304

649-405-00-X

xxxxxxx xxxxxxx (xxxxxxxxx), xxxxxx xxxxx.;

Xxxxxxxx xxx xxxxxxxx;

[X xxxxxxx xxxxxxxxxxx of xxxxxxxxxxxx xxxxxxxx xxxx xxx xxxxxxxxxxxx of crude xxx or xxxxxxx xxxxxxxx. Xx consists xxxxxxxxxxxxx of xxxxxxxxx xxxxxxxxxxxx having xxxxxx xxxxxxx xxxxxxxxxxxxx xx xxx xxxxx xx X9 xxxxxxx X12 xxx xxxxxxx xx xxx range xx xxxxxxxxxxxxx 140 °C xx 220&xxxx;&xxx;X (284&xxxx;&xxx;X xx 428&xxxx;&xxx;X).]

265-191-7

64742-88-7

XXXX XX 1

X372 (xxxxxxx xxxxxxx xxxxxx)

XXX08

H372 (xxxxxxx nervous system)

 

 

 

Xxx. Xxx. 1

H304

Xxx

X304

XŘ&Xxxxxx;XXXX III

Indexové č&xxxxxx;xxx

Xxxxx&xxxxxx;xxxx&xxxxxx; xxxxxxxxxxxx xxxxxxx&xxxxxx;xx x&xxxxxx;xxx

Číslo XX

Č&xxxxxx;xxx XXX

Xxxxxxxxxxx

Xxxxčxx&xxxxxx;

Specifické xxxxxxx. xxxxxx,

xxxxxxxxxxčx&xxxxxx; xxxxxxx

Xxxx.

Kódy xř&xxxxxx;x x xxxxxxxx&xxxxxx; xxxxxxxčxxxxx

Kódy xxxxxxxxx&xxxxxx;xx vět x xxxxxxxčxxxxx

X&xxxxxx;xx x&xxxxxx;xxxxžx&xxxxxx;xx xxxxxxů x signálních xxxx

X&xxxxxx;xx xxxxxxxxx&xxxxxx;xx vět x xxxxxxxčxxxxx

X&xxxxxx;xx xxxxň. xxxxxxxxx&xxxxxx;xx xěx x xxxxxxxčxxxxx

031-001-00-4

xxxxxxx xxxxxxxx

215-114-8

1303-00-0

Xxxx. 1X

X350

GHS08

X350

&xxxx;

&xxxx;

&xxxx;

XXXX XX 1

X372 (respiratory xxx xxxxxxxxxxxxxx xxxxxxx)

Dgr

X372 (xxxxxxxxxxx xxx xxxxxxxxxxxxxx xxxxxxx)

050-025-00-6

trichloromethylstannane

213-608-8

993-16-8

Repr. 2

X361x

XXX08

Xxx

X361x

&xxxx;

&xxxx;

&xxxx;

050-026-00-1

2-xxxxxxxxxx 10-xxxxx-4-[[2-[(2-xxxxxxxxxx)xxx]-2-xxxxxxxx]xxxx]-4-xxxxxx-7-xxx-8-xxx-3,5-xxxxxx-4-xxxxxxxxxxxxxxxxxxxx

260-828-5

57583-34-3

Repr. 2

X361x

XXX08

Xxx

X361x

 

 

&xxxx;

050-027-00-7

2-ethylhexyl 10-xxxxx-4,4-xxxxxxx-7-xxx-8-xxx-3,5-xxxxxx-4-xxxxxxxxxxxxxxxxxxxx

239-622-4

15571-58-1

Xxxx. 1X

X360X

GHS08

Xxx

X360X

&xxxx;

&xxxx;

 

601-087-00-3

2,4,4-xxxxxxxxxxxxxxxx

246-690-9

25167-70-8

Flam. Liq. 2

X225

XXX02

X225

&xxxx;

&xxxx;

X

Xxx. Xxx. 1

X304

GHS07

X304

XXXX XX 3

H336

XXX08

Xxx

X336

606-145-00-1

sulcotrione (XXX);

2-[2-xxxxxx-4-(xxxxxxxxxxxxxx)xxxxxxx]xxxxxxxxxxx-1,3-xxxxx

&xxxx;

99105-77-8

Repr. 2

X361x

XXX08

X361x

&xxxx;

X = 1

X = 10

&xxxx;

XXXX RE 2

X373 (xxxxxxx)

XXX07

X373 (xxxxxxx)

Xxxx Xxxx. 1 X

H317

GHS09

X317

Xxxxxxx Xxxxx 1

H400

Xxx

&xxxx;

Xxxxxxx Chronic 1

X410

&xxxx;

X410

607-699-00-7

xxxxxxxxxx (XXX);

(2-xxxxxxxxxxxxxx-3-xx)xxxxxx rel-(1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylate

&xxxx;

82657-04-3

Xxxx. 2

X351

XXX06

X351

&xxxx;

X = 10 000

X = 100&xxxx;000

 

Xxxxx Xxx. 3

X331

XXX08

X331

Xxxxx Xxx. 2

X300

XXX09

X300

XXXX XX 1

H372 (xxxxxxx xxxxxx)

Xxx

X372 (nervous xxxxxx)

Xxxx Xxxx. 1B

X317

&xxxx;

X317

Aquatic Acute 1

X400

&xxxx;

&xxxx;

Xxxxxxx Xxxxxxx 1

X410

&xxxx;

X410

607-700-00-0

xxxxxxxxxx (XXX);

xxxxxx (4xX)-7-xxxxxx-2-{(xxxxxxxxxxxxxxx)[4-(xxxxxxxxxxxxxxxx)xxxxxx]xxxxxxxxx}-2,5-xxxxxxxxxxxxx[1,2-x][1,3,4]xxxxxxxxxx-4x(3X)-xxxxxxxxxxx [1]

 

173584-44-6 [1]

Xxxxx Xxx. 3

X301

XXX06

X301

 

M = 1

X = 1

&xxxx;

Xxxxx Xxx. 4

X332

XXX08

X332

STOT XX 1

X372 (blood, xxxxxxx xxxxxx, xxxxx)

XXX09

X372 (xxxxx, nervous xxxxxx, xxxxx)

Xxxx Sens. 1X

X317

Xxx

X317

Xxxxxxx Xxxxx 1

H400

&xxxx;

&xxxx;

Xxxxxxx Xxxxxxx 1

X410

&xxxx;

X410

xxxxxxxx mass xx (X)- Xxxxxxxxxx and (X)- Indoxacarb 75:25;

xxxxxx 7-xxxxxx-2-{(xxxxxxxxxxxxxxx)[4-(xxxxxxxxxxxxxxxx)xxxxxx]xxxxxxxxx}-2,5-xxxxxxxxxxxxx[1,2-x][1,3,4]xxxxxxxxxx-4x(3X)-xxxxxxxxxxx [2]

144171-61-9 [2]

&xxxx;

&xxxx;

 

&xxxx;

607-702-00-1

dihexyl xxxxxxxxx

201-559-5

84-75-3

Xxxx. 1X

X360XX

XXX08

Dgr

H360FD

&xxxx;

 

 

607-703-00-7

ammoniumpentadeca- fluorooctanoate

223-320-4

3825-26-1

Xxxx. 2

X351

XXX08

X351

&xxxx;

&xxxx;

&xxxx;

Xxxx. 1X

X360X

XXX07

X360X

Xxxx.

X362

XXX05

H362

Xxxxx Xxx. 4

X332

Xxx

X332

Xxxxx Tox. 4

X302

 

X302

STOT XX 1

X372 (xxxxx)

&xxxx;

X372 (xxxxx)

Xxx Xxx.1

X318

&xxxx;

X318

607-704-00-2

xxxxxxxxxxxxxxxxx acid

206-397-9

335-67-1

Xxxx. 2

X351

XXX08

X351

&xxxx;

&xxxx;

&xxxx;

Xxxx. 1X

X360X

GHS07

X360X

Lact.

H362

XXX05

H362

Xxxxx Xxx. 4

X332

Xxx

X332

Xxxxx Xxx. 4

X302

&xxxx;

X302

STOT XX 1

X372 (liver)

 

X372 (xxxxx)

Xxx Xxx. 1

H318

 

X318

612-282-00-8

octadecylamine

204-695-3

124-30-1

Xxx. Xxx. 1

H304

XXX05

X304

&xxxx;

X = 10

X = 10

 

XXXX XX 2

X373 (gastro-intestinal xxxxx, liver, xxxxxx xxxxxx)

XXX08

X373 (xxxxxx-xxxxxxxxxx xxxxx, xxxxx, immune xxxxxx)

Xxxx Xxxxx. 2

X315

XXX09

H315

Eye Xxx. 1

X318

Xxx

X318

Xxxxxxx Acute 1

X400

&xxxx;

 

Aquatic Xxxxxxx 1

X410

 

X410

612-283-00-3

(Z)-octadec-9-enylamine

204-015-5

112-90-3

Acute Xxx. 4

X302

XXX05

X302

&xxxx;

X = 10

X = 10

&xxxx;

Xxx Xxx. 1

X304

XXX07

X304

XXXX SE 3

X335

GHS08

H335

XXXX XX 2

X373 (xxxxxx-xxxxxxxxxx xxxxx, xxxxx, xxxxxx xxxxxx)

XXX09

X373 (gastro-intestinal xxxxx, xxxxx, xxxxxx system)

Skin Xxxx. 1B

X314

Dgr

X314

Xxxxxxx Xxxxx 1

X400

&xxxx;

&xxxx;

Xxxxxxx Xxxxxxx 1

X410

&xxxx;

X410

612-284-00-9

xxxxxx, xxxxxxxxxxxx xxxxxx xxxxx

262-976-6

61788-45-2

Asp Xxx. 1

X304

XXX08

X304

&xxxx;

M = 10

X = 10

 

STOT XX 2

X373 (xxxxxx-xxxxxxxxxx xxxxx, xxxxx, immune xxxxxx)

XXX05

X373 (gastro-intestinal xxxxx, xxxxx, xxxxxx system)

Xxxx Xxxxx. 2

H315

XXX09

H315

Xxx Dam. 1

X318

Xxx

X318

Xxxxxxx Xxxxx 1

X400

 

 

Xxxxxxx Xxxxxxx 1

X410

&xxxx;

X410

612-285-00-4

xxxxxx, xxxx xxxxx

262-977-1

61788-46-3

Xxxxx Tox. 4

X302

GHS05

X302

&xxxx;

M = 10

X = 10

&xxxx;

Xxx. Tox. 1

X304

GHS07

H304

XXXX XX 3

H335

GHS08

X335

XXXX RE 2

X373 (gastro-intestinal tract, xxxxx, xxxxxx system)

XXX09

X373 (xxxxxx-xxxxxxxxxx xxxxx, liver, xxxxxx xxxxxx)

Xxxx Xxxx. 1X

X314

Xxx

X314

Xxxxxxx Acute 1

X400

 

&xxxx;

Xxxxxxx Xxxxxxx 1

X410

&xxxx;

H410

612-286-00-X

xxxxxx, tallow xxxxx

263-125-1

61790-33-8

Xxxxx Xxx. 4

X302

GHS05

X302

 

X = 10

M = 10

&xxxx;

Xxx. Xxx. 1

H304

GHS07

X304

XXXX XX 2

H373 (xxxxxx-xxxxxxxxxx xxxxx, xxxxx, immune xxxxxx)

XXX08

X373 (gastro-intestinal xxxxx, xxxxx, xxxxxx xxxxxx)

Xxxx Xxxx. 1B

H314

XXX09

H314

Xxxxxxx Xxxxx 1

X400

Xxx

&xxxx;

Xxxxxxx Chronic 1

H410

&xxxx;

X410

616-206-00-4

xxxxxxxxxxxx (XXX);

1-(4-(2-xxxxx-&xxxxx;,&xxxxx;,&xxxxx;-x-xxxxxxxxxxxxxxxxx)-2-xxxxxxxxxxxx)-3-(2,6-xxxxxxxxxxxxxxxx)xxxx

417-680-3

101463-69-8

Xxxx.

X362

XXX09

X362

&xxxx;

X = 10&xxxx;000

M = 10 000

&xxxx;

Xxxxxxx Xxxxx 1

X400

Xxx

&xxxx;

Xxxxxxx Xxxxxxx 1

X410

&xxxx;

X410

616-207-00-X

xxxxxxxxxxxxxxxxx xxxxxxxxx xxxxxxxxxxxxx

 

27083-27-8 xx 32289-58-0

Xxxx. 2

H351

GHS05

X351

 

M = 10

X = 10

 

Xxxxx Xxx. 4

X302

XXX07

H302

XXXX RE 1

X372 (respiratory xxxxx) (xxxxxxxxxx)

XXX08

X372 (xxxxxxxxxxx xxxxx) (xxxxxxxxxx)

Xxx Dam. 1

H318

XXX09

X318

Xxxx Xxxx. 1X

X317

Xxx

X317

Xxxxxxx Xxxxx 1

X400

&xxxx;

&xxxx;

Xxxxxxx Chronic 1

H410

&xxxx;

X410

616-208-00-5

X-xxxxx-2-xxxxxxxxxxx;

1-xxxxxxxxxxxxxxx-2-xxx

220-250-6

2687-91-4

Xxxx. 1X

X360X

XXX08

Xxx

X360X

&xxxx;

&xxxx;

&xxxx;

616-209-00-0

xxxxxxxxxxxxx (ISO);

3-(4,6-dimethoxypyrimidin-2-yl)-1-((N-methyl-N-methylsulfonylamino)sulfonyl)urea

407-380-0

120923-37-7

Xxxxxxx Acute 1

X400

XXX09

&xxxx;

&xxxx;

X = 100

X = 100

&xxxx;

Xxxxxxx Xxxxxxx 1

X410

Xxx

X410

616-210-00-6

xxxxxxxxxxxx (ISO);

N-(4-tertbutylbenzyl)-4-chloro-3-ethyl-1-methyl-1Hpyrazole-5- xxxxxxxxxxx

&xxxx;

119168-77-3

Xxxxx Xxx. 3

H301

XXX06

H301

&xxxx;

X = 10

X = 10

 

Acute Xxx. 4

X332

XXX08

X332

XXXX RE 2

X373 (xxxxxxxxxxxxxxxx tract) (Xxxx)

XXX09

X373 (xxxxxxxxxxxxxxxx xxxxx) (Xxxx)

Xxxx Sens. 1X

X317

Xxx

X317

Xxxxxxx Xxxxx 1

X400

 

 

Aquatic Chronic 1

X410

&xxxx;

X410

616-211-00-1

xxxxxxxxxxx (XXX);

6-xxxx-2-xxxxxxx-3-xxxxxxxxxxxxxxxx-4(3X)-xxx

&xxxx;

189278-12-4

Carc. 2

X351

XXX08

X351

 

X = 1

M = 10

&xxxx;

Xxxxxxx Acute 1

H400

GHS09

&xxxx;

Xxxxxxx Xxxxxxx 1

X410

Wng

H410

XŘ&Xxxxxx;XXXX IV

Indexové č&xxxxxx;xxx

Mezinárodní xxxxxxxxxxxx chemických x&xxxxxx;xxx

Č&xxxxxx;xxx XX

Č&xxxxxx;xxx XXX

Xxxxxxxxxxx

Xxxxčxx&xxxxxx;

Xxxxxxxxxčx&xxxxxx; xxxxxx

Pozn.

015-004-00-8

xxxxxxxxx xxxxxxxxx

244-088-0

20859-73-8

X; X15/29

X+; X26/28

Xn; X21

X32

X; R50

X; X+; X

X: 15/29-21- 26/28-32-50

X: (1/2-)3/9/14/49-8-22-30-36/37-43-45-60-61

X; R50: X &xx; 0,25 %

 

015-005-00-3

magnesium xxxxxxxxx;

trimagnesium xxxxxxxxxxx

235-023-7

12057-74-8

X; X15/29

T+; X26/28

Xn; X21

X32

X; X50

X; X+; X

X: 15/29-21-26/28-32-50

X: (1/2-)3/9/14/49-8-22-30-36/37-43-45-60-61

X; X50: C &xx; 0,25&xxxx;%

&xxxx;

015-123-00-5

xxxxxxxxxx (XXX);

ethyl-4-methylthio-m-tolyl isopropyl xxxxxxxxxxxxxxx

244-848-1

22224-92-6

X+; R26/28

X; R24

Xx; X36

X; R50-53

X+; N

X: 24-26/28-36-50/53

X: (1/2-)23-26-28-35-36/37-45-60-61

N; X50-53: X &xx; 0,25 %

N; X51-53: 0,025&xxxx;% ≤ X < 0,25&xxxx;%

X52-53: 0.0025&xxxx;% &xx; X &xx; 0,025&xxxx;%

&xxxx;

030-012-00-1

aluminium-magnesium-zinc-carbonate-hydroxide

423-570-6

169314-88-9

R53

X: 53

X: 61

&xxxx;

&xxxx;

602-006-00-4

xxxxxxxxxx;

xxxxxxxxxxxxxxxx

200-663-8

67-66-3

Xxxx. Xxx. 3; X40

Xxxx. Xxx. 3; X63

Xx; X20/22-48/20

Xx; X36/38

Xn

X: 20/22-36/38-40-48/20-63

X: (2-)36/37

&xxxx;

&xxxx;

603-097-00-3

1,1′,1″-nitrilotripropan-2-ol;

xxxxxxxxxxxxxxxxxxx

204-528-4

122-20-3

Xx; R36

Xi

X: 36

X: (2-)26

&xxxx;

&xxxx;

605-008-00-3

xxxxxxxx;

prop-2-enal;

xxxxxxxxxxxxx

203-453-4

107-02-8

X; X11

X+; X26/28

X; R24

C; X34

N; X50

X; X+; X

X: 11-24-26/28-34-50

X: (1/2-)23-26-28-36/37/39-45-61

C; X34: X ≥ 0,1&xxxx;%

X; X50: X ≥ 0,25&xxxx;%

X

607-023-00-0

xxxxx xxxxxxx

203-545-4

108-05-4

X; R11

Xxxx. Xxx. 3; X40

Xn; X20

Xx; X37

X; Xn

R: 11-20-37-40

X: 9-16-33-36/37

&xxxx;

X

607-613-00-8

xxxxxxxx xxxx xx:

&xxxx;

xxxxxxxx xxxx

 

xxxxxxxxxxxxxxx xxxx

&xxxx;

dipersuccinic xxxx

&xxxx;

xxxxxxxxxx ester xx xxxxxxxx xxxx

&xxxx;

xxxxxxxxxx xxxxx xx persuccinic xxxx

&xxxx;

xxxxxxxx xxxxxxxxx

&xxxx;

xxxxxxxx xxxx

 

xxxxxxxxxxxxxxx xxxx

&xxxx;

xxxxxxxxxxxxx xxxx

&xxxx;

xxxxxxxxxx xxxxx of xxxxxxxx xxxx

 

xxxxxxxxxx ester xx xxxxxxxxxxx acid

&xxxx;

xxxxxxxx xxxxxxxxx

&xxxx;

xxxxxx xxxx

&xxxx;

xxxxxxxxxxxxx xxxx

&xxxx;

xxxxxxxxxxx xxxx

&xxxx;

xxxxxxxxxx xxxxx of xxxxxx xxxx

 

monomethyl ester xx xxxxxxxxx xxxx

 

xxxxxxxx xxxxxxx

&xxxx;

xxxxxxxx xxxxxxxx

 

xxxxxxxx

&xxxx;

xxxxx

432-790-1

&xxxx;

X; X34

Xn; X20/21/22-68/20/21/22

X

X: 20/21/22-34-68/20/21/22

S: (1/2-)26-28-36/37/39-45

 

 

609-003-00-7

xxxxxxxxxxxx

202-716-0

98-95-3

Xxxx. Xxx. 3; R40

Repr. Xxx. 2; X60

X; X23/24/25-48/23/24/25

X52-53

X

X: 23/24/25-48/23/24/25-40-60-52/53

X: 45-53

 

 

612-120-00-6

xxxxxxxxx (XXX);

2-xxxxxx-6-xxxxx-3-xxxxxxxxxxxxxx

277-704-1

74070-46-5

Xxxx. Cat. 3; X40

X43

X; X50-53

Xn; X

X: 40-43-50/53

X: (2-)36/37-60-61

R43: X &xx; 0,1&xxxx;%

N; R50-53: X &xx; 0,25&xxxx;%

N; X51-53: 0,025&xxxx;% &xx; X &xx; 0,25 %

X52-53: 0,0025&xxxx;% ≤ X &xx; 0,025&xxxx;%

&xxxx;

613-175-00-9

epoxiconazole (ISO);

(2XX,3XX)-3-(2-xxxxxxxxxxxx)-2-(4-xxxxxxxxxxxx)-[(1X-1,2,4-xxxxxxx-1-xx)xxxxxx]xxxxxxx

406-850-2

133855-98-8

Carc. Xxx. 3; X40

Xxxx. Xxx. 2; R61

Repr. Xxx. 3; X62

X; X51-53

X; X

X: 61-40-62-51/53

X: 45-53-61

&xxxx;

&xxxx;

616-200-00-1

xxxxxxxx xxxx xx X,X&xxxxx;-xxxxxx-1,2-xxxxxxx(xxxxxxxxxx) xxx 12-xxxxxxx-X-[2-[(1-xxxxxxxx)xxxxx]xxxxx]xxxxxxxxxxxxxx xxx X,X&xxxxx;-xxxxxx-1,2-xxxxxxx(12-xxxxxxxxxxxxxxxx xxxxx)

432-430-3

 

R53

X: 53

X: 61

 

&xxxx;

648-055-00-5

pitch, xxxx xxx, xxxx-xxxx.;

[Xxx xxxxxxx xxxx the distillation xx high xxxxxxxxxxx xxxx xxx. A xxxxx xxxxx with xx xxxxxxxxxxx xxxxxxxxx xxxxx xxxx 30 °C xx 180 °C (86 °F xx 356&xxxx;&xxx;X). Xxxxxxxx xxxxxxxxx xx x xxxxxxx mixture xx xxxxx xx xxxx xxxxxxxx xxxxxxxxx xxxx xxxxxxxx hydrocarbons.]

266-028-2

65996-93-2

Carc. Cat. 1; X45

Xxxx. Xxx. 2; R46

Xxxx. Cat. 2; R60-61

X; X50-53

T; X

X: 45-46-60-61-50/53

S: 45-53-60-61

N; X50-53: C &xx; 0,025&xxxx;%

X; X51-53: 0,0025&xxxx;% &xx; C <

0,025 %

X52-53: 0,00025&xxxx;% ≤ C &xx;

0,0025&xxxx;%

&xxxx;

649-330-00-2

xxxxxxx (xxxxxxxxx), hydrodesulphurized xxxxx;

Xxx xxxxxxx point xxxxxxxx xxxxxxx naphtha;

[X xxxxxxx xxxxxxxxxxx of xxxxxxxxxxxx obtained xxxx x catalytic xxxxxxxxxxxxxxxxxxxx xxxxxxx. Xx xxxxxxxx xx xxxxxxxxxxxx having xxxxxx xxxxxxx predominantly xx the xxxxx xx X7 xxxxxxx X12 and xxxxxxx xx xxx xxxxx xx xxxxxxxxxxxxx 90&xxxx;&xxx;X xx 230&xxxx;&xxx;X (194&xxxx;&xxx;X xx 446&xxxx;&xxx;X).]

265-185-4

64742-82-1

Carc. Xxx. 2; R45

Xxxx. Xxx. 2; X46

Xx; X48/20-65

T

X: 45-46-48/20-65

X: 45-53

&xxxx;

X

649-345-00-4

xxxxxxxx xxxxxxx;

Low xxxxxxx xxxxx xxxxxxx &xxxxx; unspecified;

[X colourless, xxxxxxx petroleum distillate xxxx xx xxxx xxxx xxxxxx xx xxxxxxxxxxxxx xxxxxx xxx xxxx boils in x xxxxx of xxxxxxxxxxxxx 148,8 °C xx 204,4&xxxx;&xxx;X (300 °F xx 400 °F).]

232-489-3

8052-41-3

Xxxx. Xxx. 2; X45

Xxxx. Cat. 2; R46

Xx; X48/20-65

T

X: 45-46-48/20-65

X: 45-53

&xxxx;

P

649-405-00-X

xxxxxxx xxxxxxx (xxxxxxxxx), medium aliph.;

Xxxxxxxx xxx xxxxxxxx;

[X xxxxxxx xxxxxxxxxxx xx xxxxxxxxxxxx xxxxxxxx xxxx xxx xxxxxxxxxxxx of xxxxx xxx xx xxxxxxx xxxxxxxx. It consists xxxxxxxxxxxxx xx saturated xxxxxxxxxxxx xxxxxx xxxxxx xxxxxxx predominantly xx xxx range xx X9 xxxxxxx X12 xxx xxxxxxx in xxx range xx xxxxxxxxxxxxx 140&xxxx;&xxx;X xx 220&xxxx;&xxx;X (284&xxxx;&xxx;X xx 428&xxxx;&xxx;X).]

265-191-7

64742-88-7

Xx; X48/20-65

Xn

R: 48/20-65

X: (2-)23-24-62

&xxxx;

&xxxx;

XŘ&Xxxxxx;XXXX V

Xxxxxxx&xxxxxx; č&xxxxxx;xxx

Xxxxx&xxxxxx;xxxx&xxxxxx; xxxxxxxxxxxx chemických x&xxxxxx;xxx

Číslo XX

Č&xxxxxx;xxx XXX

Klasifikace

Xxxxčxx&xxxxxx;

Xxxxxxxxxčx&xxxxxx; xxxxxx

Xxxx.

031-001-00-4

xxxxxxx xxxxxxxx

215-114-8

1303-00-0

Xxxx. Xxx. 2; X45

X; X48/23

X

X: 45-48/23

X: 45-53

&xxxx;

X

050-025-00-6

xxxxxxxxxxxxxxxxxxxxxxx

213-608-8

993-16-8

Xxxx. Xxx. 3; X63

Xx

X: 63

S: (2-)22-36/37

&xxxx;

 

050-026-00-1

2-ethylhexyl 10-xxxxx-4-[[2-[(2-xxxxxxxxxx)xxx]-2-xxxxxxxx]xxxx]-4-xxxxxx-7-xxx-8-xxx-3,5-xxxxxx-4-xxxxxxxxxxxxxxxxxxxx

260-828-5

57583-34-3

Xxxx. Xxx. 3; X63

Xx

X: 63

S: (2-)22-36/37

 

 

050-027-00-7

2-xxxxxxxxxx 10-xxxxx-4,4-xxxxxxx-7-xxx-8-xxx-3,5-xxxxxx-4-xxxxxxxxxxxxxxxxxxxx

239-622-4

15571-58-1

Xxxx. Xxx. 2; X61

X

X: 61

S: 45-53

&xxxx;

&xxxx;

601-087-00-3

2,4,4-xxxxxxxxxxxxxxxx

246-690-9

25167-70-8

F; X11

Xx; X65

X67

X; Xx

R: 11-65-67

X: 9-16-33-62

 

X

606-145-00-1

xxxxxxxxxxx (XXX);

2-[2-xxxxxx-4-(xxxxxxxxxxxxxx)xxxxxxx]xxxxxxxxxxx-1,3-xxxxx

 

99105-77-8

Xxxx. Xxx. 3; X63

Xx; X48/22

X43

X; X50-53

Xn; X

R: 43-48/22-63-50/53

X: (2-)22-36/37-60-61

N; X50-53: X ≥ 25 %

N; X51-53: 2,5&xxxx;% &xx; X &xx; 25 %

X52-53: 0,25&xxxx;% &xx; C< 2,5&xxxx;%

X43: C &xx; 0,1&xxxx;%

&xxxx;

607-699-00-7

xxxxxxxxxx (XXX);

(2-xxxxxxxxxxxxxx-3-xx)xxxxxx xxx-(1X,3X)-3-[(1X)-2-xxxxxx-3,3,3-xxxxxxxxxxxxx-1-xx-1-xx]-2,2-xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

&xxxx;

82657-04-3

Carc. Xxx 3; X40

T; X23/25

Xx; R48/22

R43

N; X50-53

T; X

X: 23/25-40-43-48/22-50/53

X: (1/2-)23-24-36/37-38- 45-60-61

X; X50-53: X &xx; 0,0025 %

N; X51-53: 0,00025&xxxx;% &xx; C< 0,0025&xxxx;%

X52-53: 0,000025&xxxx;% &xx; X &xx; 0,00025 %

 

607-700-00-0

xxxxxxxxxx (XXX);

xxxxxx (4xX)-7-xxxxxx-2-{(xxxxxxxxxxxxxxx)[4-(xxxxxxxxxxxxxxxx)xxxxxx]xxxxxxxxx}-2,5-xxxxxxxxxxxxx[1,2-x][1,3,4]xxxxxxxxxx-4x(3X)-xxxxxxxxxxx

&xxxx;

173584-44-6

X; R25-48/25

Xx; X20

X43

X; X50-53

T; X

X: 20-25-43-48/25-50/53

X: (1/2-)24-37-45-60-61

N; R50-53: X &xx; 25 %

N; X51-53: 2,5&xxxx;% ≤ X < 25 %

R52-53: 0,25&xxxx;% &xx; X &xx; 2,5 %

&xxxx;

607-701-00-6

reaction xxxx xx (X)- Xxxxxxxxxx xxx (R)- Indoxacarb 75:25;

xxxxxx 7-xxxxxx-2-{(xxxxxxxxxxxxxxx)[4-(xxxxxxxxxxxxxxxx)xxxxxx]xxxxxxxxx}-2,5-xxxxxxxxxxxxx[1,2-x][1,3,4]xxxxxxxxxx-4x(3X)-xxxxxxxxxxx

&xxxx;

144171-61-9

X; R48/25

Xx; X20/22

X43

X; X50-53

X; X

X: 20/22-43-48/25-50/53

X: (1/2-)24-37-45-60-61

N; R50-53: X ≥ 25 %

N; X51-53: 2,5 % ≤ X &xx; 25&xxxx;%

X52-53: 0,25&xxxx;% ≤ X &xx; 2,5&xxxx;%

&xxxx;

607-702-00-1

xxxxxxx xxxxxxxxx

201-559-5

84-75-3

Repr. Xxx. 2; R60-61

X

X: 60-61

X: 45-53

&xxxx;

 

607-703-00-7

xxxxxxxxxxxxxxx- xxxxxxxxxxxxxxxxx

223-320-4

3825-26-1

Xxxx. Xxx. 3; X40

Xxxx. Xxx. 2; X61

X64

X; X48/23

Xx; X20/22-48/21/22

Xx; R41

T

R: 61-20/22-40-41- 48/23-48/21/22-64

X: 45-53

 

&xxxx;

607-704-00-2

perfluorooctanoic xxxx

206-397-9

335-67-1

Xxxx. Xxx. 3; X40

Xxxx. Cat. 2; X61

X64

X; R48/23

Xx; X20/22-48/21/22

Xi; X41

X

X: 61-20/22-40-41-48/23-48/21/22-64

X: 45-53

 

 

612-282-00-8

octadecylamine

204-695-3

124-30-1

Xx; X48/22-65

Xx; R38-41

X; X50-53

Xx; X

X: 38-41-48/22-65-50/53

S: (2-)26-36/37/39-60-61-62

N; X50-53: C ≥ 2,5&xxxx;%

X; R51-53: 0,25 % &xx; X < 2,5&xxxx;%

X52-53: 0,025&xxxx;% &xx; X &xx; 0,25&xxxx;%

&xxxx;

612-283-00-3

(Z)-octadec-9-enylamine

204-015-5

112-90-3

Xx; X22-48/22-65

X; X34

N; X50-53

X; X

X: 22-34-48/22-65-50/53

X: (1/2-)23-26-36/37/39-45-60-61-62

X; X34: X &xx; 10&xxxx;%

Xx; X36/37/38: 5&xxxx;% &xx; C &xx; 10&xxxx;%

X; X50-53: X &xx; 2,5&xxxx;%

X; X51-53: 0,25&xxxx;% ≤ C &xx; 2,5&xxxx;%

X52-53: 0,025 % &xx; X < 0,25&xxxx;%

&xxxx;

612-284-00-9

xxxxxx, xxxxxxxxxxxx xxxxxx xxxxx

262-976-6

61788-45-2

Xx; X48/22-65

Xx; R38-41

N; X50-53

Xx; N

X: 38-41-48/22-65-50/53

X: (2-)26-36/37/39-60-61-62

X; X50-53: X &xx; 2,5&xxxx;%

X; X51-53: 0,25&xxxx;% ≤ C &xx; 2,5 %

X52-53: 0,025&xxxx;% &xx; X < 0,25&xxxx;%

&xxxx;

612-285-00-4

xxxxxx, coco xxxxx

262-977-1

61788-46-3

Xn; X22-48/22-65

X; R35

X; X50-53

X; X

X: 22-35-48/22-65-50/53

X: (1/2-)23-26-36/37/39-45-60-61-62

C; X35: X ≥ 10&xxxx;%

X; X34: 5&xxxx;% &xx; C &xx; 10&xxxx;%

Xx; X36/37/38: 1 % &xx; C < 5&xxxx;%

X; R50-53: C &xx; 2,5&xxxx;%

N; X51-53: 0,25&xxxx;% ≤ C &xx; 2,5&xxxx;%

R52-53: 0,025 % &xx; X &xx; 0,25&xxxx;%

&xxxx;

612-286-00-X

xxxxxx, xxxxxx xxxxx

263-125-1

61790-33-8

Xx; X22-48/22-65

X; X35

X; 50-53

X; X

X: 22-35-48/22-65-50/53

S: (1/2-)26-36/37/39-45-60-61-62

X; X50-53: X ≥ 2,5&xxxx;%

X; X51-53: 0,25&xxxx;% &xx; X &xx; 2,5&xxxx;%

X52-53: 0,025&xxxx;% ≤ X &xx; 0,25 %

&xxxx;

616-206-00-4

xxxxxxxxxxxx (XXX);

1-(4-(2-xxxxx-&xxxxx;,&xxxxx;,&xxxxx;-x-xxxxxxxxxxxxxxxxx)-2-xxxxxxxxxxxx)-3-(2,6-xxxxxxxxxxxxxxxx)xxxx

417-680-3

101463-69-8

X64

X33

X; R50-53

X

X: 33-64-50/53

X: (2-)22-36/37-46-60-61

X; R50-53 C ≥ 0,0025&xxxx;%

X; X51-53 0,00025 % &xx; X &xx; 0,0025&xxxx;%

X52-53 0,000025&xxxx;% &xx; X < 0,00025 %

&xxxx;

616-207-00-X

xxxxxxxxxxxxxxxxx xxxxxxxxx xxxxxxxxxxxxx

 

27083-27-8 or 32289-58-0

Xxxx. Cat 3; X40

Xx; X22

X; X48/23

Xx; X41

X43

X; X50-53

T; X

X: 22-40-41-43-48/23-50/53

X: (1/2-)22-36/37/39-45-60-61

N; X50-53: X ≥ 2,5&xxxx;%

X; X51-53: 0,25 % ≤ X &xx; 2,5

R52-53: 0,025&xxxx;% &xx; X &xx; 0,25&xxxx;%

&xxxx;

616-208-00-5

X-xxxxx-2-xxxxxxxxxxx;

1-ethylpyrrolidin-2-one

220-250-6

2687-91-4

Repr. Xxx. 2; X61

X

X: 61

X: 45-53

&xxxx;

&xxxx;

616-209-00-0

xxxxxxxxxxxxx (XXX);

3-(4,6-dimethoxypyrimidin-2-yl)-1-((N-methyl-N-methylsulfonylamino)sulfonyl)urea

407-380-0

120923-37-7

N; R50-53

X

X: 50/53

X: 60-61

N; X50-53: X &xx; 0,25&xxxx;%

N; X51-53: 0,025&xxxx;% &xx; X < 0,25 %

X52-53: 0,0025&xxxx;%&xx; X &xx; 0,025&xxxx;%

&xxxx;

616-210-00-6

xxxxxxxxxxxx (ISO);

X-(4-xxxxxxxxxxxxxxx)-4-xxxxxx-3-xxxxx-1-xxxxxx-1Xxxxxxxxx-5- xxxxxxxxxxx

&xxxx;

119168-77-3

Xn; X20/22

X43

X; X50-53

Xx; X

R: 20/22-43-50/53

X: (2-)24-37-46-60-61

X; R50-53: X &xx; 2,5&xxxx;%

X; X51-53: 0,25 % &xx; X < 2,5&xxxx;%

R52-53: 0,025&xxxx;% &xx; X &xx; 0,25&xxxx;%

&xxxx;

616-211-00-1

xxxxxxxxxxx (XXX);

6-xxxx-2-xxxxxxx-3-xxxxxxxxxxxxxxxx-4(3X)-xxx

&xxxx;

189278-12-4

Xxxx. Xxx. 3; R40

N; X50-53

Xx; N

X: 40-50/53

X: (2-)36/37-46-60-61

&xxxx;

&xxxx;